INDUSTRY
Discover how we're helping companies deliver better patient outcomes through differentiated platforms, consulting, and operations services
Accenture surveyed 720 healthcare providers (HCPs) globally on how operations and needs changed during COVID-19 and the effects for patients and pharmas.
Accenture's Patient Survey sets out changes in care during coronavirus and found a major shift to virtual care.
MedTech companies can take swift action to help solve for the COVID-19 crisis with a mindset of agility and responsible innovation.
Accenture knows life science companies are at the center of the COVID-19 pandemic to develop tests & treatments for people in need.
Life sciences is evolving rapidly from selling products to delivering value through better patient outcomes.
We work with our pharmaceutical, biotech, medical technology, distributor and consumer health clients globally to redefine the future of the life sciences industry: combining the latest technology with scientific breakthroughs to revolutionize how medical treatments are discovered, developed and delivered to patients around the world.
New science: Biopharma’s new growth engine
Biopharma is facing compressive disruption that could impact traditional approaches. Find out how New Science can reshape the biopharma landscape and deliver better patient outcomes.
READ MOREAccenture's video shows how New Science can reshape the biopharma landscape and patient care to overcome compressive disruption. See more.
View TranscriptAccenture Life Sciences offers a full range of services in Strategy, Consulting, Accenture Interactive, Operations and Technology that help deliver more personalized healthcare and better patient outcomes.
Accenture supports forces with Siemens Healthineers in digitizing its customer service processes.
Accenture helped a biopharma company implement a patient-centered platform to manage the delivery of a personalized gene therapy solution.
A new SAP S/4 HANA ERP solution ushers Merck KGaA Healthcare into a digital future.
Accenture's research takes a human-centered approach to evaluate the activities and interactions of HCPs in oncology needed to improve patient care.
Discover four essential steps to gain widespread adoption of precision oncology.
Accenture research reveals how companies can navigate the impediments to the value and progress that digitalization can drive. Learn more.
Our Life Sciences solutions are helping businesses deliver exceptional patient experiences. Discover how our awards distinguish us as an industry leader.
MICROSOFT
2020
EVEREST GROUP PEAK MATRIX REPORT
2020
EVEREST GROUP PEAK MATRIX REPORT
2019
We are proud to collaborate with leading women in Life Sciences in their quest to advance science and patient care.
Accenture and Springboard Enterprises, a leading network of influencers, investors and innovators dedicated to building high-growth companies led by women, are excited to celebrate "Women Transforming Industries". b.well, Medable, Obsess, and Reflaunt are leveraging technology to advance the retail, health, and life sciences industries with ground-breaking innovations.
Accenture and Springboard share a common commitment to gender parity and together we’ll help propel the growth of women-led companies like these.
Life Sciences consultants weigh in on how pharma, biotech, medtech and consumer health companies can improve patient outcomes.
Accenture's Laura Westercamp takes a look at how consumer medical devices are changing lives.
Explore the five strategies for overcoming barriers to scale AI in biopharma.
Our Carly Guenther explains how manufacturers can build patient trust and ensure counterfeit COVID-19 related treatments.
Knowledge of trends and insights are important to Accenture. Join our live thought leader-hosted events and watch on-demand sessions.
Accenture and Springboard Enterprises are celebrating “Women Transforming Industries” and the organization’s 20th anniversary by honoring four women CEOs in the retail and health industries for their technological innovation.
Collaboration will leverage cloud and data-driven insights to accelerate drug development, increase operational agility, reduce technology costs and develop the workforce of the future.
This approach aims to enable pediatric oncology physicians and researchers to better analyze patient data, with the potential to improve precision medicine.
